Artificial neural network models for prediction of intestinal permeability of oligopeptides

BackgroundOral delivery is a highly desirable property for candidate drugs under development. Computational modeling could provide a quick and inexpensive way to assess the intestinal permeability of a molecule. Although there have been several studies aimed at predicting the intestinal absorption of chemical compounds, there have been no attempts to predict intestinal permeability on the basis of peptide sequence information. To develop models for predicting the intestinal permeability of peptides, we adopted an artificial neural network as a machine-learning algorithm. The positive control data consisted of intestinal barrier-permeable peptides obtained by the peroral phage display technique, and the negative control data were prepared from random sequences.ResultsThe capacity of our models to make appropriate predictions was validated by statistical indicators including sensitivity, specificity, enrichment curve, and the area under the receiver operating characteristic (ROC) curve (the ROC score). The training and test set statistics indicated that our models were of strikingly good quality and could discriminate between permeable and random sequences with a high level of confidence.ConclusionWe developed artificial neural network models to predict the intestinal permeabilities of oligopeptides on the basis of peptide sequence information. Both binary and VHSE (principal components score V ectors of H ydrophobic, S teric and E lectronic properties) descriptors produced statistically significant training models; the models with simple neural network architectures showed slightly greater predictive power than those with complex ones. We anticipate that our models will be applicable to the selection of intestinal barrier-permeable peptides for generating peptide drugs or peptidomimetics.

[1]  Jing Lin,et al.  The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery. , 2003, Current topics in medicinal chemistry.

[2]  E. Lien,et al.  Caco-2 cell permeability vs human gastrointestinal absorption: QSPR analysis. , 2000, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[3]  Shengshi Z. Li,et al.  A new set of amino acid descriptors and its application in peptide QSARs. , 2005, Biopolymers.

[4]  William J Egan,et al.  Prediction of intestinal permeability. , 2002, Advanced drug delivery reviews.

[5]  D. E. Patterson,et al.  Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies , 1988 .

[6]  M. Brandsch,et al.  Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1. , 2003, Journal of medicinal chemistry.

[7]  C. Pidgeon,et al.  Intestinal Peptide Transport Systems and Oral Drug Availability , 1999, Pharmaceutical Research.

[8]  Jianping Wu,et al.  Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides. , 2006, Journal of agricultural and food chemistry.

[9]  S. Walker,et al.  Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). , 1988, British journal of clinical pharmacology.

[10]  Ken Chen,et al.  Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis. , 2005, Journal of proteome research.

[11]  H. Takanaga,et al.  Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids. , 1995, Biochemical and biophysical research communications.

[12]  C. Springer,et al.  PostDOCK: a structural, empirical approach to scoring protein ligand complexes. , 2005, Journal of medicinal chemistry.

[13]  Yi Han,et al.  Predicting Caco-2 Cell Permeation Coefficients of Organic Molecules Using Membrane-Interaction QSAR Analysis , 2002, J. Chem. Inf. Comput. Sci..

[14]  T. Kennedy Managing the drug discovery/development interface , 1997 .

[15]  J. Riordan,et al.  The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. , 1986, Biochemical and biophysical research communications.

[16]  M. Hediger,et al.  Human Intestinal H+/Peptide Cotransporter , 1995, The Journal of Biological Chemistry.

[17]  K. Siebert,et al.  Quantitative structure-activity relationship modeling of peptide and protein behavior as a function of amino acid composition. , 2001, Journal of agricultural and food chemistry.

[18]  F. Burden,et al.  Robust QSAR models using Bayesian regularized neural networks. , 1999, Journal of medicinal chemistry.

[19]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[20]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[21]  G Folkers,et al.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  L. Olsen,et al.  Development of a QSAR Model for Binding of Tripeptides and Tripeptidomimetics to the Human Intestinal Di-/Tripeptide Transporter hPEPT1 , 2006, Pharmaceutical Research.

[23]  Gilles Klopman,et al.  ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  S. Stavchansky,et al.  Link between drug absorption solubility and permeability measurements in Caco-2 cells. , 1998, Journal of pharmaceutical sciences.

[25]  P. Swaan Recent Advances in Intestinal Macromolecular Drug Delivery via Receptor-Mediated Transport Pathways , 1998, Pharmaceutical Research.

[26]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[27]  Pingping Guan,et al.  Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201. , 2005, Journal of medicinal chemistry.

[28]  Kazuya Nakao,et al.  Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability. , 2005, Bioorganic & medicinal chemistry.

[29]  David A Winkler,et al.  Predictive Bayesian neural network models of MHC class II peptide binding. , 2005, Journal of molecular graphics & modelling.

[30]  M. Brandsch,et al.  Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1. , 2005, Journal of medicinal chemistry.

[31]  Ismael Zamora,et al.  pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[32]  A. Menon,et al.  Peptide-mediated transcytosis of phage display vectors in MDCK cells. , 2000, Biochemical and biophysical research communications.

[33]  Peter C. Jurs,et al.  Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..

[34]  Frank R. Burden,et al.  Predictive Human Intestinal Absorption QSAR Models Using Bayesian Regularized Neural Networks , 2005 .

[35]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery. 5. Correlation of Caco-2 Permeation with Simple Molecular Properties , 2004, J. Chem. Inf. Model..